Page last updated: 2024-08-18

isomethyleugenol and imatinib mesylate

isomethyleugenol has been researched along with imatinib mesylate in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (66.67)24.3611
2020's1 (33.33)2.80

Authors

AuthorsStudies
Li, T; Lu, T; Mokhtari, D; Welsh, N1
Alley, WR; Goetz, JA; Hussein, A; Mann, BF; Matei, DE; Mechref, Y; Menning, N; Novotny, MV; Svoboda, M; Vasseur, JA1
Ammerpohl, O; Böhm, R; Bruckmueller, H; Cascorbi, I; Kaehler, M; Kolarova, J; Litterst, M; Nagel, I1

Other Studies

3 other study(ies) available for isomethyleugenol and imatinib mesylate

ArticleYear
Effects of Imatinib Mesylate (Gleevec) on human islet NF-kappaB activation and chemokine production in vitro.
    PloS one, 2011, Volume: 6, Issue:9

    Topics: Adaptor Proteins, Signal Transducing; Benzamides; Chemokines; Flow Cytometry; HSP27 Heat-Shock Proteins; Humans; I-kappa B Proteins; Imatinib Mesylate; In Vitro Techniques; Interleukin-8; Methylation; NF-KappaB Inhibitor alpha; Phosphorylation; Piperazines; Pyrimidines; Real-Time Polymerase Chain Reaction; Receptors, TNF-Related Apoptosis-Inducing Ligand; Transcription Factor RelA

2011
N-linked glycan structures and their expressions change in the blood sera of ovarian cancer patients.
    Journal of proteome research, 2012, Apr-06, Volume: 11, Issue:4

    Topics: Antineoplastic Combined Chemotherapy Protocols; Benzamides; Biomarkers, Tumor; Carbohydrate Sequence; Case-Control Studies; Docetaxel; Female; Fucose; Glycomics; Humans; Imatinib Mesylate; Immunoglobulin G; Methylation; Ovarian Neoplasms; Piperazines; Polysaccharides; Pyrimidines; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Taxoids

2012
Genome‑wide expression and methylation analyses reveal aberrant cell adhesion signaling in tyrosine kinase inhibitor‑resistant CML cells.
    Oncology reports, 2022, Volume: 48, Issue:2

    Topics: Cell Adhesion; Drug Resistance, Neoplasm; Fibronectins; Fusion Proteins, bcr-abl; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Methylation; Protein Kinase Inhibitors; RNA, Messenger; Signal Transduction

2022